Literature DB >> 26295203

Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology.

Ping-Wu Zhang1, Amanda M Haidet-Phillips1, Jacqueline T Pham1, Youngjin Lee1, Yuqing Huo1, Pentti J Tienari2, Nicholas J Maragakis1, Rita Sattler1,3, Jeffrey D Rothstein1,3,4.   

Abstract

Astrocytes are instrumental to major brain functions, including metabolic support, extracellular ion regulation, the shaping of excitatory signaling events and maintenance of synaptic glutamate homeostasis. Astrocyte dysfunction contributes to numerous developmental, psychiatric and neurodegenerative disorders. The generation of adult human fibroblast-derived induced pluripotent stem cells (iPSCs) has provided novel opportunities to study mechanisms of astrocyte dysfunction in human-derived cells. To overcome the difficulties of cell type heterogeneity during the differentiation process from iPSCs to astroglial cells (iPS astrocytes), we generated homogenous populations of iPS astrocytes using zinc-finger nuclease (ZFN) technology. Enhanced green fluorescent protein (eGFP) driven by the astrocyte-specific glial fibrillary acidic protein (GFAP) promoter was inserted into the safe harbor adeno-associated virus integration site 1 (AAVS1) locus in disease and control-derived iPSCs. Astrocyte populations were enriched using Fluorescence Activated Cell Sorting (FACS) and after enrichment more than 99% of iPS astrocytes expressed mature astrocyte markers including GFAP, S100β, NFIA and ALDH1L1. In addition, mature pure GFP-iPS astrocytes exhibited a well-described functional astrocytic activity in vitro characterized by neuron-dependent regulation of glutamate transporters to regulate extracellular glutamate concentrations. Engraftment of GFP-iPS astrocytes into rat spinal cord grey matter confirmed in vivo cell survival and continued astrocytic maturation. In conclusion, the generation of GFAP::GFP-iPS astrocytes provides a powerful in vitro and in vivo tool for studying astrocyte biology and astrocyte-driven disease pathogenesis and therapy.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  GFAP; astrocyte; iPSC; induced pluripotent stem cells; zinc finger nuclease

Mesh:

Substances:

Year:  2015        PMID: 26295203      PMCID: PMC4715664          DOI: 10.1002/glia.22903

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  54 in total

1.  Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes.

Authors:  Luni Emdad; Sunita L D'Souza; Harini P Kothari; Zulekha A Qadeer; Isabelle M Germano
Journal:  Stem Cells Dev       Date:  2011-07-26       Impact factor: 3.272

Review 2.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

3.  Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome.

Authors:  Russell C DeKelver; Vivian M Choi; Erica A Moehle; David E Paschon; Dirk Hockemeyer; Sebastiaan H Meijsing; Yasemin Sancak; Xiaoxia Cui; Eveline J Steine; Jeffrey C Miller; Phillip Tam; Victor V Bartsevich; Xiangdong Meng; Igor Rupniewski; Sunita M Gopalan; Helena C Sun; Kathleen J Pitz; Jeremy M Rock; Lei Zhang; Gregory D Davis; Edward J Rebar; Iain M Cheeseman; Keith R Yamamoto; David M Sabatini; Rudolf Jaenisch; Philip D Gregory; Fyodor D Urnov
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

4.  Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.

Authors:  Yun Li; Rita Sattler; Eun Ju Yang; Alice Nunes; Yoko Ayukawa; Sadia Akhtar; Grace Ji; Ping-Wu Zhang; Jeffrey D Rothstein
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

5.  Directed differentiation of functional astroglial subtypes from human pluripotent stem cells.

Authors:  Robert Krencik; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2011-10-13       Impact factor: 13.491

6.  Specification of transplantable astroglial subtypes from human pluripotent stem cells.

Authors:  Robert Krencik; Jason P Weick; Yan Liu; Zhi-Jian Zhang; Su-Chun Zhang
Journal:  Nat Biotechnol       Date:  2011-05-22       Impact factor: 54.908

7.  Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.

Authors:  Sophia T Papadeas; Sarah E Kraig; Colin O'Banion; Angelo C Lepore; Nicholas J Maragakis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

8.  Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells.

Authors:  Eirini P Papapetrou; Gabsang Lee; Nirav Malani; Manu Setty; Isabelle Riviere; Laxmi M S Tirunagari; Kyuichi Kadota; Shoshannah L Roth; Patricia Giardina; Agnes Viale; Christina Leslie; Frederic D Bushman; Lorenz Studer; Michel Sadelain
Journal:  Nat Biotechnol       Date:  2010-12-12       Impact factor: 54.908

Review 9.  Astrocytes and disease: a neurodevelopmental perspective.

Authors:  Anna V Molofsky; Robert Krencik; Robert Krenick; Erik M Ullian; Erik Ullian; Hui-hsin Tsai; Benjamin Deneen; William D Richardson; Ben A Barres; David H Rowitch
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

10.  Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.

Authors:  Amanda M Haidet-Phillips; Mark E Hester; Carlos J Miranda; Kathrin Meyer; Lyndsey Braun; Ashley Frakes; SungWon Song; Shibi Likhite; Matthew J Murtha; Kevin D Foust; Meghan Rao; Amy Eagle; Anja Kammesheidt; Ashley Christensen; Jerry R Mendell; Arthur H M Burghes; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2011-08-10       Impact factor: 54.908

View more
  13 in total

Review 1.  Genome editing: a robust technology for human stem cells.

Authors:  Arun Pandian Chandrasekaran; Minjung Song; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

2.  Rhesus iPSC Safe Harbor Gene-Editing Platform for Stable Expression of Transgenes in Differentiated Cells of All Germ Layers.

Authors:  So Gun Hong; Ravi Chandra Yada; Kyujoo Choi; Arnaud Carpentier; T Jake Liang; Randall K Merling; Colin L Sweeney; Harry L Malech; Moonjung Jung; Marcus A F Corat; Aisha A AlJanahi; Yongshun Lin; Huimin Liu; Ilker Tunc; Xujing Wang; Maryknoll Palisoc; Stefania Pittaluga; Manfred Boehm; Thomas Winkler; Jizhong Zou; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 3.  EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.

Authors:  Lauren Taylor Rosenblum; Davide Trotti
Journal:  Adv Neurobiol       Date:  2017

4.  A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants.

Authors:  Katie J Ryan; Charles C White; Kruti Patel; Jishu Xu; Marta Olah; Joseph M Replogle; Michael Frangieh; Maria Cimpean; Phoebe Winn; Allison McHenry; Belinda J Kaskow; Gail Chan; Nicole Cuerdon; David A Bennett; Justin D Boyd; Jaime Imitola; Wassim Elyaman; Philip L De Jager; Elizabeth M Bradshaw
Journal:  Sci Transl Med       Date:  2017-12-20       Impact factor: 17.956

Review 5.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

6.  Human neural progenitors derived from integration-free iPSCs for SCI therapy.

Authors:  Ying Liu; Yiyan Zheng; Shenglan Li; Haipeng Xue; Karl Schmitt; Georgene W Hergenroeder; Jiaqian Wu; Yuanyuan Zhang; Dong H Kim; Qilin Cao
Journal:  Stem Cell Res       Date:  2017-01-05       Impact factor: 2.020

7.  Aberrant iPSC-derived human astrocytes in Alzheimer's disease.

Authors:  V C Jones; R Atkinson-Dell; A Verkhratsky; L Mohamet
Journal:  Cell Death Dis       Date:  2017-03-23       Impact factor: 8.469

Review 8.  May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.

Authors:  Nicholas Brookhouser; Sreedevi Raman; Christopher Potts; David A Brafman
Journal:  Cells       Date:  2017-02-06       Impact factor: 6.600

Review 9.  Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.

Authors:  Adelaide Tousley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2016-06-28

Review 10.  Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease.

Authors:  Layla T Ghaffari; Alexander Starr; Andrew T Nelson; Rita Sattler
Journal:  Front Neurosci       Date:  2018-02-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.